APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ivermectin for Human

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ivermectin for Human Market Outlook and Growth Opportunities 2026

2 January 2026192 pages

Choose your research edition.

Industry ResearchIvermectin for Human Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Ivermectin for Human Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Ivermectin for Human Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ivermectin for Human Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Ivermectin for Human Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Ivermectin for Human market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ivermectin for Human is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ivermectin for Human is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ivermectin for Human is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ivermectin for Human market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ivermectin for Human market include Arbor Pharms LLC, Edenbridge Pharms, Galderma Laboratories LP, Perrigo Company plc, TARO, TEVA Pharms USA, Wellona Pharma and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ivermectin for Human market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ivermectin for Human and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ivermectin for Human sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ivermectin for Human market size, projected growth trends, production technologies, key applications, and end-use industries.

Ivermectin for Human Segment by Company

Arbor Pharms LLC

Edenbridge Pharms

Galderma Laboratories LP

Perrigo Company plc

TARO

TEVA Pharms USA

Wellona Pharma

Merck

Ivermectin for Human Segment by Type

Injection

Oral

Topical (Cream and Lotion)

Ivermectin for Human Segment by Application

For Onchocerciasis Treatment

For Headlice Treatment

Others

Ivermectin for Human Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Ivermectin for Human status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ivermectin for Human market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ivermectin for Human significant trends, drivers, influence factors in global and regions.

6. To analyze Ivermectin for Human competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ivermectin for Human market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ivermectin for Human and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ivermectin for Human.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ivermectin for Human market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ivermectin for Human industry.

Chapter 3: Detailed analysis of Ivermectin for Human manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ivermectin for Human in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ivermectin for Human in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ivermectin for Human Industry Trends Table 2. Ivermectin for Human Industry Drivers Table 3. Ivermectin for Human Industry Opportunities and Challenges Table 4. Ivermectin for Human Industry Restraints Table 5. Global Ivermectin for Human Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ivermectin for Human Revenue Share by Company (2021-2026) Table 7. Global Ivermectin for Human Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Ivermectin for Human Sales Volume Share by Company (2021-2026) Table 9. Global Ivermectin for Human Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Ivermectin for Human Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ivermectin for Human Key Company Manufacturing Base & Headquarters Table 12. Global Ivermectin for Human Company, Product Type & Application Table 13. Global Ivermectin for Human Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ivermectin for Human by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Table 18. Significant Companies of Oral Table 19. Significant Companies of Topical (Cream and Lotion) Table 20. Global Ivermectin for Human Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 21. Global Ivermectin for Human Sales Volume by Type (2021-2026) & (Kg) Table 22. Global Ivermectin for Human Sales Volume by Type (2027-2032) & (Kg) Table 23. Global Ivermectin for Human Sales Volume Share by Type (2021-2026) Table 24. Global Ivermectin for Human Sales Volume Share by Type (2027-2032) Table 25. Global Ivermectin for Human Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Ivermectin for Human Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Ivermectin for Human Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Ivermectin for Human Sales Value Share by Type (2021-2026) Table 29. Global Ivermectin for Human Sales Value Share by Type (2027-2032) Table 30. Significant Companies of For Onchocerciasis Treatment Table 31. Significant Companies of For Headlice Treatment Table 32. Significant Companies of Others Table 33. Global Ivermectin for Human Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 34. Global Ivermectin for Human Sales Volume by Application (2021-2026) & (Kg) Table 35. Global Ivermectin for Human Sales Volume by Application (2027-2032) & (Kg) Table 36. Global Ivermectin for Human Sales Volume Share by Application (2021-2026) Table 37. Global Ivermectin for Human Sales Volume Share by Application (2027-2032) Table 38. Global Ivermectin for Human Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Ivermectin for Human Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Ivermectin for Human Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Ivermectin for Human Sales Value Share by Application (2021-2026) Table 42. Global Ivermectin for Human Sales Value Share by Application (2027-2032) Table 43. Global Ivermectin for Human Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 44. Global Ivermectin for Human Sales by Region (2021-2026) & (Kg) Table 45. Global Ivermectin for Human Sales Market Share by Region (2021-2026) Table 46. Global Ivermectin for Human Sales by Region (2027-2032) & (Kg) Table 47. Global Ivermectin for Human Sales Market Share by Region (2027-2032) Table 48. Global Ivermectin for Human Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Ivermectin for Human Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Ivermectin for Human Sales Value Share by Region (2021-2026) Table 51. Global Ivermectin for Human Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Ivermectin for Human Sales Value Share by Region (2027-2032) Table 53. Global Ivermectin for Human Market Average Price (US$/Kg) by Region (2021-2026) Table 54. Global Ivermectin for Human Market Average Price (US$/Kg) by Region (2027-2032) Table 55. Global Ivermectin for Human Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 56. Global Ivermectin for Human Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Ivermectin for Human Sales by Country (2021-2026) & (Kg) Table 58. Global Ivermectin for Human Sales Market Share by Country (2021-2026) Table 59. Global Ivermectin for Human Sales by Country (2027-2032) & (Kg) Table 60. Global Ivermectin for Human Sales Market Share by Country (2027-2032) Table 61. Global Ivermectin for Human Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Ivermectin for Human Sales Value Market Share by Country (2021-2026) Table 63. Global Ivermectin for Human Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Ivermectin for Human Sales Value Market Share by Country (2027-2032) Table 65. Arbor Pharms LLC Company Information Table 66. Arbor Pharms LLC Business Overview Table 67. Arbor Pharms LLC Ivermectin for Human Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 68. Arbor Pharms LLC Ivermectin for Human Product Portfolio Table 69. Arbor Pharms LLC Recent Development Table 70. Edenbridge Pharms Company Information Table 71. Edenbridge Pharms Business Overview Table 72. Edenbridge Pharms Ivermectin for Human Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 73. Edenbridge Pharms Ivermectin for Human Product Portfolio Table 74. Edenbridge Pharms Recent Development Table 75. Galderma Laboratories LP Company Information Table 76. Galderma Laboratories LP Business Overview Table 77. Galderma Laboratories LP Ivermectin for Human Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 78. Galderma Laboratories LP Ivermectin for Human Product Portfolio Table 79. Galderma Laboratories LP Recent Development Table 80. Perrigo Company plc Company Information Table 81. Perrigo Company plc Business Overview Table 82. Perrigo Company plc Ivermectin for Human Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 83. Perrigo Company plc Ivermectin for Human Product Portfolio Table 84. Perrigo Company plc Recent Development Table 85. TARO Company Information Table 86. TARO Business Overview Table 87. TARO Ivermectin for Human Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 88. TARO Ivermectin for Human Product Portfolio Table 89. TARO Recent Development Table 90. TEVA Pharms USA Company Information Table 91. TEVA Pharms USA Business Overview Table 92. TEVA Pharms USA Ivermectin for Human Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 93. TEVA Pharms USA Ivermectin for Human Product Portfolio Table 94. TEVA Pharms USA Recent Development Table 95. Wellona Pharma Company Information Table 96. Wellona Pharma Business Overview Table 97. Wellona Pharma Ivermectin for Human Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 98. Wellona Pharma Ivermectin for Human Product Portfolio Table 99. Wellona Pharma Recent Development Table 100. Merck Company Information Table 101. Merck Business Overview Table 102. Merck Ivermectin for Human Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 103. Merck Ivermectin for Human Product Portfolio Table 104. Merck Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Ivermectin for Human Distributors List Table 108. Ivermectin for Human Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Ivermectin for Human Product Image Figure 2. Global Ivermectin for Human Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ivermectin for Human Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ivermectin for Human Sales (2021-2032) & (Kg) Figure 5. Global Ivermectin for Human Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Ivermectin for Human Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Image Figure 10. Oral Image Figure 11. Topical (Cream and Lotion) Image Figure 12. Global Ivermectin for Human Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 13. Global Ivermectin for Human Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Ivermectin for Human Sales Volume Share by Type (2021-2032) Figure 15. Global Ivermectin for Human Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Ivermectin for Human Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Ivermectin for Human Sales Value Share by Type (2021-2032) Figure 18. For Onchocerciasis Treatment Image Figure 19. For Headlice Treatment Image Figure 20. Others Image Figure 21. Global Ivermectin for Human Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 22. Global Ivermectin for Human Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Ivermectin for Human Sales Volume Share by Application (2021-2032) Figure 24. Global Ivermectin for Human Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Ivermectin for Human Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Ivermectin for Human Sales Value Share by Application (2021-2032) Figure 27. Global Ivermectin for Human Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 28. Global Ivermectin for Human Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Ivermectin for Human Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Ivermectin for Human Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Ivermectin for Human Sales Value (2021-2032) & (US$ Million) Figure 32. North America Ivermectin for Human Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Ivermectin for Human Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Ivermectin for Human Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Ivermectin for Human Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Ivermectin for Human Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Ivermectin for Human Sales Value (2021-2032) & (US$ Million) Figure 38. South America Ivermectin for Human Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Ivermectin for Human Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Ivermectin for Human Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Ivermectin for Human Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Ivermectin for Human Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Ivermectin for Human Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Ivermectin for Human Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Ivermectin for Human Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Oral
  • Topical (Cream and Lotion)
Applications
  • For Onchocerciasis Treatment
  • For Headlice Treatment
  • Others
Companies covered
  • Arbor Pharms LLC
  • Edenbridge Pharms
  • Galderma Laboratories LP
  • Perrigo Company plc
  • TARO
  • TEVA Pharms USA
  • Wellona Pharma
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ivermectin for Human Sales Value (2021-2032)
  4. 1.2.2 Global Ivermectin for Human Sales Volume (2021-2032)
  5. 1.2.3 Global Ivermectin for Human Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ivermectin for Human Market Dynamics
  1. 2.1 Ivermectin for Human Industry Trends
  2. 2.2 Ivermectin for Human Industry Drivers
  3. 2.3 Ivermectin for Human Industry Opportunities and Challenges
  4. 2.4 Ivermectin for Human Industry Restraints
3 Ivermectin for Human Market by Company
  1. 3.1 Global Ivermectin for Human Company Revenue Ranking in 2025
  2. 3.2 Global Ivermectin for Human Revenue by Company (2021-2026)
  3. 3.3 Global Ivermectin for Human Sales Volume by Company (2021-2026)
  4. 3.4 Global Ivermectin for Human Average Price by Company (2021-2026)
  5. 3.5 Global Ivermectin for Human Company Ranking (2024-2026)
  6. 3.6 Global Ivermectin for Human Company Manufacturing Base and Headquarters
  7. 3.7 Global Ivermectin for Human Company Product Type and Application
  8. 3.8 Global Ivermectin for Human Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ivermectin for Human Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ivermectin for Human Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ivermectin for Human Market by Type
  1. 4.1 Ivermectin for Human Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Oral
  4. 4.1.3 Topical (Cream and Lotion)
  5. 4.2 Global Ivermectin for Human Sales Volume by Type
  6. 4.2.1 Global Ivermectin for Human Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Ivermectin for Human Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Ivermectin for Human Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Ivermectin for Human Sales Value by Type
  10. 4.3.1 Global Ivermectin for Human Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Ivermectin for Human Sales Value by Type (2021-2032)
  12. 4.3.3 Global Ivermectin for Human Sales Value Share by Type (2021-2032)
5 Ivermectin for Human Market by Application
  1. 5.1 Ivermectin for Human Application Introduction
  2. 5.1.1 For Onchocerciasis Treatment
  3. 5.1.2 For Headlice Treatment
  4. 5.1.3 Others
  5. 5.2 Global Ivermectin for Human Sales Volume by Application
  6. 5.2.1 Global Ivermectin for Human Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ivermectin for Human Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Ivermectin for Human Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Ivermectin for Human Sales Value by Application
  10. 5.3.1 Global Ivermectin for Human Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ivermectin for Human Sales Value by Application (2021-2032)
  12. 5.3.3 Global Ivermectin for Human Sales Value Share by Application (2021-2032)
6 Ivermectin for Human Regional Sales and Value Analysis
  1. 6.1 Global Ivermectin for Human Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ivermectin for Human Sales by Region (2021-2032)
  3. 6.2.1 Global Ivermectin for Human Sales by Region: 2021-2026
  4. 6.2.2 Global Ivermectin for Human Sales by Region (2027-2032)
  5. 6.3 Global Ivermectin for Human Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ivermectin for Human Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ivermectin for Human Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ivermectin for Human Sales Value by Region (2027-2032)
  9. 6.5 Global Ivermectin for Human Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ivermectin for Human Sales Value (2021-2032)
  12. 6.6.2 North America Ivermectin for Human Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ivermectin for Human Sales Value (2021-2032)
  15. 6.7.2 Europe Ivermectin for Human Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ivermectin for Human Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ivermectin for Human Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ivermectin for Human Sales Value (2021-2032)
  21. 6.9.2 South America Ivermectin for Human Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ivermectin for Human Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ivermectin for Human Sales Value Share by Country, 2025 VS 2032
7 Ivermectin for Human Country-level Sales and Value Analysis
  1. 7.1 Global Ivermectin for Human Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ivermectin for Human Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ivermectin for Human Sales by Country (2021-2032)
  4. 7.3.1 Global Ivermectin for Human Sales by Country (2021-2026)
  5. 7.3.2 Global Ivermectin for Human Sales by Country (2027-2032)
  6. 7.4 Global Ivermectin for Human Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ivermectin for Human Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ivermectin for Human Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ivermectin for Human Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ivermectin for Human Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ivermectin for Human Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ivermectin for Human Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ivermectin for Human Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ivermectin for Human Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ivermectin for Human Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ivermectin for Human Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ivermectin for Human Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ivermectin for Human Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ivermectin for Human Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ivermectin for Human Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ivermectin for Human Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ivermectin for Human Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ivermectin for Human Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ivermectin for Human Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ivermectin for Human Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ivermectin for Human Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ivermectin for Human Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ivermectin for Human Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ivermectin for Human Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ivermectin for Human Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ivermectin for Human Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ivermectin for Human Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ivermectin for Human Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ivermectin for Human Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ivermectin for Human Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ivermectin for Human Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ivermectin for Human Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ivermectin for Human Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Arbor Pharms LLC
  2. 8.1.1 Arbor Pharms LLC Company Information
  3. 8.1.2 Arbor Pharms LLC Business Overview
  4. 8.1.3 Arbor Pharms LLC Ivermectin for Human Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Arbor Pharms LLC Ivermectin for Human Product Portfolio
  6. 8.1.5 Arbor Pharms LLC Recent Developments
  7. 8.2 Edenbridge Pharms
  8. 8.2.1 Edenbridge Pharms Company Information
  9. 8.2.2 Edenbridge Pharms Business Overview
  10. 8.2.3 Edenbridge Pharms Ivermectin for Human Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Edenbridge Pharms Ivermectin for Human Product Portfolio
  12. 8.2.5 Edenbridge Pharms Recent Developments
  13. 8.3 Galderma Laboratories LP
  14. 8.3.1 Galderma Laboratories LP Company Information
  15. 8.3.2 Galderma Laboratories LP Business Overview
  16. 8.3.3 Galderma Laboratories LP Ivermectin for Human Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Galderma Laboratories LP Ivermectin for Human Product Portfolio
  18. 8.3.5 Galderma Laboratories LP Recent Developments
  19. 8.4 Perrigo Company plc
  20. 8.4.1 Perrigo Company plc Company Information
  21. 8.4.2 Perrigo Company plc Business Overview
  22. 8.4.3 Perrigo Company plc Ivermectin for Human Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Perrigo Company plc Ivermectin for Human Product Portfolio
  24. 8.4.5 Perrigo Company plc Recent Developments
  25. 8.5 TARO
  26. 8.5.1 TARO Company Information
  27. 8.5.2 TARO Business Overview
  28. 8.5.3 TARO Ivermectin for Human Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 TARO Ivermectin for Human Product Portfolio
  30. 8.5.5 TARO Recent Developments
  31. 8.6 TEVA Pharms USA
  32. 8.6.1 TEVA Pharms USA Company Information
  33. 8.6.2 TEVA Pharms USA Business Overview
  34. 8.6.3 TEVA Pharms USA Ivermectin for Human Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 TEVA Pharms USA Ivermectin for Human Product Portfolio
  36. 8.6.5 TEVA Pharms USA Recent Developments
  37. 8.7 Wellona Pharma
  38. 8.7.1 Wellona Pharma Company Information
  39. 8.7.2 Wellona Pharma Business Overview
  40. 8.7.3 Wellona Pharma Ivermectin for Human Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Wellona Pharma Ivermectin for Human Product Portfolio
  42. 8.7.5 Wellona Pharma Recent Developments
  43. 8.8 Merck
  44. 8.8.1 Merck Company Information
  45. 8.8.2 Merck Business Overview
  46. 8.8.3 Merck Ivermectin for Human Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Merck Ivermectin for Human Product Portfolio
  48. 8.8.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ivermectin for Human Value Chain Analysis
  2. 9.1.1 Ivermectin for Human Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ivermectin for Human Sales Mode & Process
  6. 9.2 Ivermectin for Human Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ivermectin for Human Distributors
  9. 9.2.3 Ivermectin for Human Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst